Key Highlights

  • Senti Biosciences shares closed down 11% at $0.39.
  • Subsidiary Senti Holdings finalized a $4 million senior secured convertible note issuance to Celadon Partners SPV 24.
  • The financing secures immediate funding while introducing potential share dilution.
  • The note establishes formal Debt obligations previously indicated in May 1, 2026 regulatory filings.

Senti Biosciences, Inc. (NASDAQ: SNTI) shares closed down 11% at $0.39 after Subsidiary Senti Holdings finalized a $4 million senior secured convertible note issuance to Celadon Partners SPV 24.

What Happened

The transaction secures immediate funding while introducing potential share dilution and establishing formal debt obligations, as previously indicated in the company's May 1, 2026 regulatory filings.

Market Reaction

Shares fell as investors weighed the dilution and new debt obligations tied to the convertible note against the immediate funding it provides.

Outlook

The disclosed information does not include specific forward guidance beyond the completed convertible note issuance; investors are likely to watch for how the new debt obligations and potential dilution affect the company's Capital Structure going forward.